Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Spectral Medical Inc EDTXF


Primary Symbol: T.EDT

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

Recent & Breaking News (TSX:EDT)

Spectral Medical Supports World Sepsis Day

GlobeNewswire September 13, 2023

Spectral Medical Featured in New Episode of 'The Balancing Act' Airing on Lifetime TV Focused on Endotoxic Septic Shock

GlobeNewswire September 8, 2023

CORRECTION - Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing

GlobeNewswire September 7, 2023

Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing

GlobeNewswire September 7, 2023

Spectral Medical Inc. Announces Upsizing of Previously Announced Bought Deal Convertible Note Financing to C$5.5M

GlobeNewswire August 22, 2023

Spectral Medical Highlights New Episode of 'The Balancing Act' Airing on Lifetime TV Focused on Endotoxic Shock

GlobeNewswire August 16, 2023

Spectral Medical Announces Second Quarter Results and Provides Corporate Update

GlobeNewswire August 10, 2023

Spectral Medical Inc. Announces C$5 Million Bought Deal Convertible Note Financing

GlobeNewswire August 10, 2023

Spectral Medical Announces Tigris Clinical Trial Update

GlobeNewswire July 25, 2023

Spectral Medical Announces the Opening of Three Additional Tigris Clinical Trial Sites

GlobeNewswire July 5, 2023

Spectral Medical Appoints Former FDA Director, Dr. David W. Feigal, Jr., to Its Board of Directors

GlobeNewswire June 27, 2023

Spectral Medical Provides Update on Continued Favorable Tigris Clinical Trial Enrollment

GlobeNewswire June 20, 2023

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswire June 8, 2023

Spectral Medical Provides Update on Favorable Tigris Clinical Trial Enrollment

GlobeNewswire May 30, 2023

Spectral Medical Hosts Successful Investigator Meeting; Expected to Help Bolster Enrollment Activities

GlobeNewswire May 24, 2023

Spectral Medical Announces First Quarter Results and Provides Corporate Update

GlobeNewswire May 12, 2023

Spectral Medical Inc. Announces Director Resignation

GlobeNewswire May 4, 2023

Spectral Medical Announces Positive Results of EUPHAS-2 Clinical Trial Evaluating PMX in Critically Ill Endotoxemic Septic Shock Patients

GlobeNewswire April 18, 2023

Spectral Medical Announces Investor Update Conference Call

GlobeNewswire April 6, 2023

Spectral Medical Announces Fourth Quarter and Fiscal 2022 Results and Provides Corporate Update

GlobeNewswire March 24, 2023